Mutated BRAF also promotes the secretion of IL-1α and IL-1β, innate inflammatory mediators which can drive tumor cells to protect themselves from immune attack by up-regulating molecules that inhibit the function of anti-tumor lymphocytes [5]. The gene discussed is BRAF; the disease is neoplasm.